Virginia Commonwealth University
The goal of Phase IIa Trial is to determine the feasibility and acceptability of telehealth C-SMART for patients with primary brain tumor and mild neurocognitive deficits (N=36) and their caregivers (N=36) A subset (n=10) of participants will undergo rs-fMRI both pre- and post-C-SMART to test feasibility of advanced functional imaging in this population.
Glioma, Mixed
Mild Neurocognitive Disorder
Brain Tumor
C-SMART
Study Type : | OBSERVATIONAL |
Estimated Enrollment : | 72 participants |
Official Title : | C-SMART for Patients With Primary Brain Tumors: A Feasibility and Acceptability Pilot of a Novel Neuropsychological Intervention |
Actual Study Start Date : | 2023-09-15 |
Estimated Primary Completion Date : | 2026-09-30 |
Estimated Study Completion Date : | 2026-09-30 |
Information not available for Arms and Intervention/treatment
Ages Eligible for Study: | 18 Years |
Sexes Eligible for Study: | ALL |
Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
RECRUITING
Virginia Commonwealth University
Richmond, Virginia, United States, 23298